Formosa Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 0.573 million compared to TWD 0.979 million a year ago. Net loss was TWD 143.89 million compared to TWD 104.62 million a year ago. Basic loss per share from continuing operations was TWD 1.08 compared to TWD 0.96 a year ago.
For the nine months, sales was TWD 31.17 million compared to TWD 1.32 million a year ago. Net loss was TWD 279.39 million compared to TWD 307.69 million a year ago. Basic loss per share from continuing operations was TWD 2.31 compared to TWD 3.01 a year ago.